Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Summary

Seer, a pioneering life sciences company focused on proteomics, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference in Boston, MA. The company's management team is set to engage in a fireside chat on Wednesday, August 14th at 3:00 p.m. Eastern Time.

Investors and interested parties can access a live webcast of the session through the Investor section of Seer's website at investor.seer.bio. For those unable to attend in real-time, an archived replay will be made available on the company's website following the conference, ensuring widespread access to this important corporate update.

REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 44^th Annual Growth Conference in Boston, MA.

Seer’s management is scheduled to participate in a fireside chat on Wednesday, August 14^th at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact:
Carrie Mendivil
investor@seer.bio

Media Inquiries:
Patrick Schmidt
pr@seer.bio

FAQ

When is Seer participating in the Canaccord Genuity 44th Annual Growth Conference?

Seer is participating in the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14th, 2024. The company's management will be part of a fireside chat at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.

How can investors access Seer's presentation at the Canaccord Genuity conference?

Investors can access a live webcast of Seer's presentation through the Investor section of the company's website at investor.seer.bio. An archived replay will also be available on the website after the conference.

What is the focus of Seer's business as mentioned in the press release?

Seer is described as a leading life sciences company commercializing a disruptive new platform for proteomics, which is the large-scale study of proteins.

Where is the Canaccord Genuity 44th Annual Growth Conference being held?

The Canaccord Genuity 44th Annual Growth Conference is being held in Boston, MA.